Australia markets closed

CASI Pharmaceuticals Inc (ENM.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.52000.0000 (0.00%)
At close: 10:38AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-26,938
-26,938
-41,014
-36,654
-48,287
Depreciation & amortisation
3,741
3,741
2,422
1,815
1,959
Stock-based compensation
7,217
7,217
7,010
7,770
7,821
Change in working capital
-7,818
-7,818
-6,650
-3,218
-3,318
Accounts receivable
3,422
3,422
-3,170
-5,158
-3,352
Inventory
-9,739
-9,739
-4,231
-551
3,186
Accounts payable
1,149
1,149
1,066
1,491
-1,540
Other working capital
-22,208
-22,208
-26,700
-42,342
-45,213
Other non-cash items
-
-
1,189
6,555
17,828
Net cash provided by operating activities
-19,967
-19,967
-21,088
-26,842
-25,886
Cash flows from investing activities
Investments in property, plant and equipment
-2,241
-2,241
-5,612
-15,500
-19,327
Purchases of investments
-51,754
-51,754
-7,425
0
-6,318
Sales/maturities of investments
44,322
44,322
37,622
0
0
Other investing activities
-
-
6,436
-5,201
2,226
Net cash used for investing activities
-9,673
-9,673
31,159
-20,691
-20,719
Cash flows from financing activities
Debt repayment
0
0
-4,001
-1,548
0
Common stock issued
0
0
0
32,500
45,099
Common stock repurchased
-278
-278
-3,267
0
-
Other financing activities
-738
-738
-
-2,019
-2,818
Net cash used provided by (used for) financing activities
-907
-907
-3,267
29,642
47,153
Net change in cash
-30,029
-30,029
8,408
-18,360
3,443
Cash at beginning of period
47,112
47,112
38,704
57,064
53,621
Cash at end of period
17,083
17,083
47,112
38,704
57,064
Free cash flow
Operating cash flow
-19,967
-19,967
-21,088
-26,842
-25,886
Capital expenditure
-2,241
-2,241
-5,612
-15,500
-19,327
Free cash flow
-22,208
-22,208
-26,700
-42,342
-45,213